CLLS - Cellectis S.A.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5528.25M
Enterprise Value 3213.79M
Trailing P/E N/A
Forward P/E 1-4.69
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)46.44
Price/Book (mrq)1.43
Enterprise Value/Revenue 318.79
Enterprise Value/EBITDA 6-1.85

Trading Information

Stock Price History

Beta (3Y Monthly) 1.54
52-Week Change 3-59.68%
S&P500 52-Week Change 3-0.33%
52 Week High 329.97
52 Week Low 311.70
50-Day Moving Average 314.77
200-Day Moving Average 317.14

Share Statistics

Avg Vol (3 month) 3122.95k
Avg Vol (10 day) 3133.49k
Shares Outstanding 535.93M
Float 28.07M
% Held by Insiders 10.00%
% Held by Institutions 130.16%
Shares Short (Jul 31, 2019) 4183.19k
Short Ratio (Jul 31, 2019) 41.64
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 40.43%
Shares Short (prior month Jun 28, 2019) 4331.94k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,032.11%

Management Effectiveness

Return on Assets (ttm)-14.12%
Return on Equity (ttm)-23.78%

Income Statement

Revenue (ttm)11.38M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)-64.90%
Gross Profit (ttm)18.69M
EBITDA -115.5M
Net Income Avi to Common (ttm)-95.06M
Diluted EPS (ttm)-2.24
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)396.97M
Total Cash Per Share (mrq)9.35
Total Debt (mrq)47.81M
Total Debt/Equity (mrq)11.80
Current Ratio (mrq)8.48
Book Value Per Share (mrq)8.57

Cash Flow Statement

Operating Cash Flow (ttm)-79.23M
Levered Free Cash Flow (ttm)-49.69M